ROSELLI, ROSALINDA
 Distribuzione geografica
Continente #
NA - Nord America 152
EU - Europa 139
AF - Africa 20
AS - Asia 11
OC - Oceania 1
Totale 323
Nazione #
US - Stati Uniti d'America 149
IT - Italia 116
CI - Costa d'Avorio 19
FI - Finlandia 5
SG - Singapore 5
GB - Regno Unito 4
CA - Canada 3
DE - Germania 3
FR - Francia 3
IE - Irlanda 3
CN - Cina 2
IR - Iran 2
PL - Polonia 2
EG - Egitto 1
IN - India 1
KZ - Kazakistan 1
NL - Olanda 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 323
Città #
Naples 40
Chandler 32
Ashburn 13
Millbury 12
Formia 10
Lawrence 9
Napoli 9
Boston 4
Des Moines 4
Langhirano 4
Lappeenranta 4
Perugia 4
Salerno 4
Dublin 3
San Mateo 3
Toronto 3
Ancona 2
Beijing 2
Fairfield 2
Kronberg 2
Piemonte 2
Sesto Fiorentino 2
Warsaw 2
Abbiategrasso 1
Arzano 1
Auckland 1
Bologna 1
Casalnuovo Di Napoli 1
Eindhoven 1
Hackney 1
Helsinki 1
Košice 1
Milan 1
Perm 1
Phoenix 1
Potenza 1
Pune 1
Rome 1
Seattle 1
Trieste 1
Vico Equense 1
Visone 1
Wilmington 1
Woodbridge 1
Wrestedt 1
Totale 194
Nome #
Identification of cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1 53
Discovery of a Potent and Orally Active Dual GPBAR1/CysLT1R Modulator for the Treatment of Metabolic Fatty Liver Disease 49
GPBAR1 activation by C6-substituted hyodeoxycholane analogues protect against colitis 35
The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy 28
Discovery of a Novel Class of Dual GPBAR1 Agonists-RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders 24
The bile acid receptor GPBAR1 modulates CCL2/CCR2 signaling at the liver sinusoidal/macrophage interface and reverses acetaminophen-induced liver toxicity 21
Structural Basis for Developing Multitarget Compounds Acting on Cysteinyl Leukotriene Receptor 1 and G-Protein-Coupled Bile Acid Receptor 1 18
Expanding the Library of 1,2,4-Oxadiazole Derivatives: Discovery of New Farnesoid X Receptor (FXR) Antagonists/Pregnane X Receptor (PXR) Agonists 17
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma 13
GLP-1 Mediates Regulation of Colonic ACE2 Expression by the Bile Acid Receptor GPBAR1 in Inflammation 13
Combinatorial targeting of G-protein-coupled bile acid receptor 1 and cysteinyl leukotriene receptor 1 reveals a mechanistic role for bile acids and leukotrienes in drug-induced liver injury 12
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis 12
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 12
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling 11
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling 10
Inverse Virtual Screening for the rapid re-evaluation of the presumed biological safe profile of natural products. The case of steviol from Stevia rebaudiana glycosides on farnesoid X receptor (FXR) 8
Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis 7
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH 5
Modeling Inflammatory Bowel Disease by Intestinal Organoids 2
Totale 350
Categoria #
all - tutte 1.710
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.710


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202140 7 1 11 1 5 1 2 5 2 1 2 2
2021/202272 4 2 0 2 0 3 2 6 0 12 18 23
2022/2023112 12 8 2 8 17 9 11 7 18 3 12 5
2023/2024126 26 16 14 12 5 5 6 26 9 5 2 0
Totale 350